| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/283195A0 |
| P698 | PubMed publication ID | 6985716 |
| P2860 | cites work | Prostacyclin can replace heparin in haemodialysis in dogs | Q33492862 |
| Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments | Q34480048 | ||
| The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets | Q35896881 | ||
| The effects of thrombin on phytohemagglutinin receptor sites in human platelets | Q36196195 | ||
| Selective Binding Site for [3H]Prostacyclin on Platelets | Q37035596 | ||
| Relationships Between Platelets and Coagulation Factors in Hemostasis | Q39722730 | ||
| Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis | Q39725109 | ||
| Modulation of human platelet adenylate cyclase by prostacyclin (PGX) | Q40061238 | ||
| Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets | Q40093715 | ||
| Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal | Q59065336 | ||
| Separation of human platelets from plasma proteins including factor VIIIVWF by a combined albumin gradient-gel filtration method using hepes buffer | Q67313242 | ||
| Stimulation of human platelet adenylate cyclase by prostaglandin D2 | Q68704678 |
| Q42008672 | 4,4'-Di-isothiocyanatostilbene-2,2'-disulphonic acid ('DIDS') activates protein kinase C and Na+/H+ exchange in human platelets via alpha 2A-adrenergic receptors |
| Q33821916 | A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa |
| Q42161870 | A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom |
| Q37004238 | A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors |
| Q54046126 | ADP receptor‐induced activation of guanine‐nucleotide‐binding proteins in human platelet membranes |
| Q37562150 | ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets |
| Q36222072 | Activation-dependent redistribution of the adhesion plaque protein, talin, in intact human platelets |
| Q59095973 | Adenosine diphosphate induces binding of von Willebrand factor to human platelets |
| Q35824103 | Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen |
| Q42245156 | Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure |
| Q24561798 | Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation |
| Q73061864 | Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes |
| Q40141187 | Characteristics of an ADP receptor mediating platelet activation |
| Q37352044 | Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis |
| Q67593584 | Differences between platelet and microparticle glycoprotein IIb/IIIa |
| Q70927498 | Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress |
| Q73605811 | Effect of 2-(1-piperazinyl)-4H-pyrido[1,2-a]pyrimidin-4-one (AP155) on human platelets in vitro |
| Q34527505 | Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin |
| Q70110930 | Effect of forskolin on platelet deaggregation and cyclic AMP generation |
| Q71914466 | Endogenous ADP prevents PGE1-induced tyrosine dephosphorylation of focal adhesion kinase in thrombin-activated platelets |
| Q70201984 | Evidence that three adhesive proteins interact with a common recognition site on activated platelets |
| Q34526333 | Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase |
| Q41896469 | Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit. |
| Q39461091 | Fibrinogen and fibrin: biochemistry and pathophysiology |
| Q33476961 | Fibrinogen interaction with platelet receptors |
| Q56601465 | Formation and regulation of platelet and fibrin hemostatic plug |
| Q34528200 | Functionally thrombasthenic state in normal platelets following the administration of ticlopidine |
| Q36314768 | Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets |
| Q72932817 | Identification of the fibrinogen receptor on human platelets by photoaffinity labeling |
| Q72779664 | Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies |
| Q72868857 | Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP |
| Q36299694 | Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline |
| Q41556911 | Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa |
| Q46717216 | Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron |
| Q34624945 | Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation |
| Q72789257 | Interaction of fibrinogen with staphylococcal clumping factor and with platelets |
| Q72892582 | Investigation of possible mechanisms of pyridoxal 5′-phosphate inhibition of platelet reactions |
| Q37026661 | Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody |
| Q72956213 | Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen γ chain |
| Q93901011 | Mechanism of action of two new pyrimidoquinoline and isoquinoline derivatives in human platelets |
| Q72799254 | Monoclonal antibodies against human platelet glycoprotein IIIa |
| Q37369997 | Nitric oxide released from activated platelets inhibits platelet recruitment |
| Q78173894 | Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines |
| Q36368770 | Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) |
| Q71055870 | Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia |
| Q37874113 | Platelet receptors. |
| Q30442042 | Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling |
| Q41915162 | Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets |
| Q40917716 | Reconstruction of platelet proteins into phospholipid vesicles. Functional proteoliposomes |
| Q41446372 | Recycling of platelet phosphorylation and cytoskeletal assembly |
| Q42821559 | Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor |
| Q73068645 | Reversible exposure of human platelet fibrinogen receptors by antiplatelet tetraspanin monoclonal antibodies via induction of a conformational change in membrane glycoprotein IIb/IIIa complex |
| Q34619920 | Role of thrombospondin in platelet aggregation |
| Q36780079 | S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds |
| Q37178111 | S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme |
| Q72592797 | Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets |
| Q37553472 | Synthesis of analogs of human platelet membrane glycoprotein IIb-IIIa complex by chicken peripheral blood thrombocytes |
| Q37556824 | The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets |
| Q70151754 | The fibrinogen-dependent pathway of platelet aggregation |
| Q71845050 | The structural properties and contractile force of a clot |
| Q36983829 | Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets |
| Q33486711 | Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma |
| Q33442517 | Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome |
| Q33444536 | Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor |
| Q70123739 | [Significance of the endothelium of the vascular wall for maintaining hemostasis] |
| Q24301146 | gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors |
Search more.